7498 Results (Page 299 of 300)
Pharmaceuticals Markets Research Reports
China Cardiac Resynchronization Therapy Market
China Cardiac Resynchronization Therapy Market was valued at $386 Mn in 2022 and is estimated to reach $639 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period. The global surge in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a significant catalyst contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major contributors to this market include companies such as Medtronic, Boston Scientific, Abbott, Siemens Healthineers, MicroPort Apsara, Lepu Medical Technology Co., Beijing Easywell Medical Device Co., Shenzhen Lepu Heart Valve Technology Co., Terumo Corporation, and Osram Health.
South Africa Cancer Induced Bone Diseases Therapeutics Market
South Africa Cancer Induced Bone Diseases Therapeutics Market valued at $8 Mn in 2022, projected to reach $15 Mn by 2030 with a 7.03% CAGR. The key drivers of this industry include the rising burden of cancer, increased healthcare spending, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Fresenius, AstraZeneca, Merck, Eli Lilly, Johnson & Johnson, Amgen, and Novartis among others.
Kenya Cancer Induced Bone Diseases Therapeutics Market
Kenya Cancer Induced Bone Diseases Therapeutics Market valued at $1 Mn in 2022, projected to reach $2 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the rising incidence of cancer, the demographic shift to an aging population, and supportive government initiatives. The industry is primarily dominated by players such as Avenue Healthcare, AstraZeneca, Merck, Eli Lilly, Johnson & Johnson, Amgen, and Novartis among others.
Philippines Cardiac Arrhythmia Therapeutics Market
Philippines Cardiac Arrhythmia Therapeutics Market valued at $16 Mn in 2022, projected to reach $26 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include rising incidence of cardiac arrhythmias, increased healthcare spending, and technological advances. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, United Laboratories, Siemens, and Zuellig among others.
Kenya Cardiac Arrhythmia Therapeutics Market
Kenya Cardiac Arrhythmia Therapeutics Market valued at $5 Mn in 2022, projected to reach $9 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure, and evolving treatment landscape. The industry is primarily dominated by players such as Abbott, Pfizer, Metropolis, Mediheal, Chemicare, Johnson & Johnson, and Medtronic among others.
Indonesia Cardiac Arrhythmia Therapeutics Market
Indonesia Cardiac Arrhythmia Therapeutics Market valued at $43 Mn in 2022, projected to reach $68 Mn by 2030 with a 5.8% CAGR. The key drivers of this industry include a surge in the prevalence of cardiac arrhythmias, expanding healthcare access, and an evolving treatment landscape. The industry is primarily dominated by players such as Abbott, Philips, GE Healthcare, Boston Scientific, Stryker, Biotronik, and Esaote among others.
Japan Cardiac Arrhythmia Therapeutics Market
Japan Cardiac Arrhythmia Therapeutics Market valued at $448 Mn in 2022, projected to reach $730 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the rising prevalence of cardiac arrhythmias, supportive government initiatives, and technological advancements. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, Olympus, Terumo, and Esaote among others.
France Cardiac Arrhythmia Therapeutics Market
France Cardiac Arrhythmia Therapeutics Market valued at $198 Mn in 2022, projected to reach $288 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increasing prevalence of cardiac conditions, technological advancements, and the emerging therapeutics landscape. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Philips, GE, Nuubo, and Boston Scientific among others.
Canada Cardiac Arrhythmia Therapeutics Market
Canada Cardiac Arrhythmia Therapeutics Market valued at $576 Mn in 2022, projected to reach $904 Mn by 2030 with a 5.8% CAGR. The key drivers of this industry include the rising prevalence of CVDs, technological advancements, and supportive government initiatives. The industry is primarily dominated by players such as Abbott, Medtronic, GE, Pfizer, Johnson & Johnson, Siemens, and Biosense Webster among others.
China Cardiac Arrhythmia Therapeutics Market
China Cardiac Arrhythmia Therapeutics Market valued at $579 Mn in 2022, projected to reach $1,017 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include a surge in the prevalence of cardiac arrhythmias, government initiatives, and technological advancements. The industry is primarily dominated by players such as Abbott, MicroPort, Lepu Medical Technologies, Boston Scientific, Terumo, and Merck among others.
Canada LASIK Surgery Market Analysis
Canada LASIK Surgery Market was valued at $282.40 Mn in 2023 and is predicted to grow at a CAGR of 5.21% from 2023 to 2030, to $402.96 Mn by 2030. The key drivers of this industry include high prevalence, growing disposable income, and increasing marketing. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Egypt Cardiac Arrhythmia Therapeutics Market
Egypt Cardiac Arrhythmia Therapeutics Market valued at $20 Mn in 2022, projected to reach $35 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the increasing prevalence of cardiac arrhythmias, government initiatives, and technological advances. The industry is primarily dominated by players such as Abbott, Hikma, EPharm, Pharco, Sanofi, Boehringer Ingelheim, and AstraZeneca among others.
US LASIK Surgery Market Analysis
US LASIK Surgery Market was valued at $1,482.60 Mn in 2023 and is predicted to grow at a CAGR of 3.21% from 2023 to 2030, to $1,849.59 Mn by 2030. The key drivers of this industry include rising prevalence, high disposable income, and medical tourism destinations. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Brazil Cardiac Arrhythmia Therapeutics Market
Brazil Cardiac Arrhythmia Therapeutics Market valued at $180 Mn in 2022, projected to reach $305 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising burden of cardiac conditions, technological advancements, and growing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Biolab Sanus, Johnson & Johnson, and Boston Scientific among others.
Saudi Arabia LASIK Surgery Market Analysis
Saudi Arabia LASIK Surgery Market was valued at $60.01 Mn in 2023 and is predicted to grow at a CAGR of 6.71% from 2023 to 2030, to $94.55 Mn by 2030. The key drivers of this industry include rising prevalence, growing disposable income, and government initiatives. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
UAE LASIK Surgery Market Analysis
UAE LASIK Surgery Market was valued at $17.65 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $ 26.91 Mn by 2030. The key drivers of this industry include rising prevalence, high disposable income, and medical tourism destinations. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Brazil Kidney Cancer Therapeutics Market Analysis
The Brazil Kidney Cancer Therapeutics Market was valued at $157.25 Mn in 2023 and is predicted to grow at a CAGR of 5.86% from 2023 to 2030, to $234.27 Mn by 2030. Brazil Kidney Cancer Therapeutics Market is growing due to an Increase in Geriatric Population, a Rise in Lifestyle disorders, and Growing Pipeline of Novel Therapies. Amgen Inc., Bayer AG, F. Hoffmann-La Roche, Bristol Myers Squibb, and Abbott Laboratories are the major companies operating in the Brazil Kidney Cancer Therapeutics Market.
Brazil LASIK Surgery Market Analysis
Brazil LASIK Surgery Market was valued at $88.25 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $134.55 Mn by 2030. The key drivers of this industry include rising prevalence, evolving consumer habits, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Singapore Cardiac Arrhythmia Therapeutics Market Analysis
Singapore Cardiac Arrhythmia Therapeutics Market valued at $9 Mn in 2022, projected to reach $14 Mn by 2030 with a 6.4% CAGR. The key drivers of this industry include the rising incidence of cardiac arrhythmias, government initiatives, and technological advances. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, Acutus, Siemens, Affectis, and Medtronic among others.
China Kidney Cancer Therapeutics Market Analysis
The China Kidney Cancer Therapeutics Market was valued at $505.64 Mn in 2023 and is predicted to grow at a CAGR of 6.36% from 2023 to 2030, to $788.55 Mn by 2030. China Kidney Cancer Therapeutics Market is growing due to Increased Incidence of Kidney Diseases, Demand for Immunotherapies, Government initiatives, and funding. The industry is primarily dominated by players such as Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India) and Novartis AG (Switzerland).
Mexico LASIK Surgery Market Analysis
Mexico LASIK Surgery Market was valued at $52.95 Mn in 2023 and is predicted to grow at a CAGR of 5.46% from 2023 to 2030, to $76.82 Mn by 2030. The key drivers of this industry include rising prevalence, increasing awareness, and medical tourism. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
France LASIK Surgery Market Analysis
France LASIK Surgery Market was valued at $97.08 Mn in 2023 and is predicted to grow at a CAGR of 4.21% from 2023 to 2030, to $129.56 Mn by 2030. The key drivers of this industry include a high prevalence, strong economy, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
UAE Cardiac Arrhythmia Therapeutics Market Analysis
UAE Cardiac Arrhythmia Therapeutics Market valued at $36 Mn in 2022, projected to reach $61 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the increasing prevalence of cardiac diseases, technological advancements, and growing public health programs. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, GE, Siemens, Philips, Johnson & Johnson, and Boston Scientific among others.
Germany LASIK Surgery Market Analysis
Germany LASIK Surgery Market was valued at $129.20 Mn in 2023 and is predicted to grow at a CAGR of 3.41% from 2023 to 2030, to $163.38 Mn by 2030. The key drivers of this industry include a high prevalence, strong economy, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
UK Cardiac Arrhythmia Therapeutics Market Analysis
UK Cardiac Arrhythmia Therapeutics Market valued at $187 Mn in 2022, projected to reach $252 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising burden of cardiac arrhythmias, increasing focus on preventive care, and technological advancements. The industry is primarily dominated by players such as Abbott, Teva, Bayer, AstraZeneca, Boston Scientific, Sanofi, and Pfizer among others.